An MLH1 haplotype is over-represented on chromosomes carrying an HNPCC predisposing mutation in MLH1

被引:9
|
作者
Hutter, P [1 ]
Wijnen, J
Rey-Berthod, C
Thiffault, I
Verkuijlen, P
Farber, D
Hamel, N
Bapat, B
Thibodeau, SN
Burn, J
Wu, J
MacNamara, E
Heinimann, K
Chong, G
Foulkes, WD
机构
[1] Hop Valaisans, Inst Cent, Genet Unit, Sion, Switzerland
[2] Leiden Univ, Med Ctr, Dept Human & Clin Genet, Leiden, Netherlands
[3] McGill Univ, Sir MB Davis Jewish Gen Hosp, Dept Diagnost Med, Montreal, PQ, Canada
[4] McGill Univ, Sir MB Davis Jewish Gen Hosp, Dept Med, Montreal, PQ, Canada
[5] McGill Univ, Sir MB Davis Jewish Gen Hosp, Dept Oncol, Montreal, PQ, Canada
[6] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada
[7] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada
[8] Mayo Clin, Mol Genet Lab, Rochester, MN USA
[9] Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[10] St Marys Hosp, NW Reg Genet Lab, Manchester M13 0JH, Lancs, England
[11] Univ Clin, Div Med Genet, Res Grp Human Genet, Basel, Switzerland
[12] McGill Univ, Dept Oncol & Human Genet, Program Canc Genet, Montreal, PQ, Canada
关键词
D O I
10.1136/jmg.39.5.323
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: The mismatch repair gene, MLH1, appears to occur as two main haplotypes at least in white populations. These are referred to as A and G types with reference to the A/G polymorphism at IVS14-19. On the basis of preliminary experimental data, we hypothesised that deviations from the expected frequency of these two haplotypes could exist in carriers of disease associated MLH1 germline mutations. Methods: We assembled a series (n = 119) of germline MLH1 mutation carriers in whom phase between the haplotype and the mutation had been conclusively established. Controls, without cancer, were obtained from each contributing centre. Cases and controls were genotyped for the polymorphism in IVS14. Results: Overall, 66 of 119 MLH1 mutations occurred on a G haplotype (55.5%), compared with 315 G haplotypes on 804 control chromosomes (39.2%, p=0.001). The odds ratio (OR) of a mutation occurring on a G rather than an A haplotype was 1.93 (95% Cl 1.29 to 2.91). When we compared the haplotype frequencies in mutation bearing chromosomes carried by people of different nationalities with those seen in pooled controls, all groups showed a ratio of A/G haplotypes that was skewed towards G, except the Dutch group. On further analysis of the type of each mutation, it was notable that, compared with control frequencies, deletion and substitution mutations were preferentially represented on the G haplotype (p=0.003 and 0.005, respectively). Conclusion: We have found that disease associated mutations in MLH1 appear to occur more often on one of only two known ancient haplotypes. The underlying reason for this observation is obscure, but it is tempting to suggest a possible role of either distant regulatory sequences or of chromatin structure influencing access to DNA sequence. Alternatively, differential behaviour of otherwise similar haplotypes should be considered as prime areas for further study.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 50 条
  • [31] Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review
    Takanori Yokoyama
    Kazuhiro Takehara
    Nao Sugimoto
    Keika Kaneko
    Etsuko Fujimoto
    Mika Okazawa-Sakai
    Shinichi Okame
    Yuko Shiroyama
    Takashi Yokoyama
    Norihiro Teramoto
    Shozo Ohsumi
    Shinya Saito
    Kazuho Imai
    Kokichi Sugano
    [J]. BMC Cancer, 18
  • [32] Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review
    Yokoyama, Takanori
    Takehara, Kazuhiro
    Sugimoto, Nao
    Kaneko, Keika
    Fujimoto, Etsuko
    Okazawa-Sakai, Mika
    Okame, Shinichi
    Shiroyama, Yuko
    Yokoyama, Takashi
    Teramoto, Norihiro
    Ohsumi, Shozo
    Saito, Shinya
    Imai, Kazuho
    Sugano, Kokichi
    [J]. BMC CANCER, 2018, 18
  • [33] Microsatellite instability and expression of MLH1 in mucinous adenocarcinoma of the distal duodenum associated with HNPCC
    Appalaneni, V
    John, S
    Walsh, M
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S100 - S100
  • [34] Results of h MLH1 and h MSH2 mutation analysis among Iranian patients with HNPCC
    Abedin, N
    Noorinayer, B
    Karimianpour, N
    Chitsaz, NR
    Zali, MR
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S389 - S389
  • [35] Three synchronous primary carcinomas in a patient with HNPCC associated with a novel germline mutation in MLH1: Case report
    Valenzuela, Cristian D.
    Moore, Harvey G.
    Huang, William C.
    Reich, Elsa W.
    Yee, Herman
    Ostrer, Harry
    Pachter, H. Leon
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7
  • [36] Alu element insertion in the MLH1 exon 6 coding sequence as a mutation predisposing to Lynch syndrome
    Solassol, Jerome
    Larrieux, Marion
    Leclerc, Julie
    Ducros, Vincent
    Corsini, Carole
    Chiesa, Jean
    Pujol, Pascal
    Rey, Jean-Marc
    [J]. HUMAN MUTATION, 2019, 40 (06) : 716 - 720
  • [37] Immunohistochemistry for MLH1, MSH2, MSH6, and PMS2 identifies most cases with germline HNPCC mutations and methylation of the MLH1 promoter
    Frankel, WL
    Hampel, H
    Nakagawa, H
    Morrison, C
    de la Chapelle, A
    [J]. LABORATORY INVESTIGATION, 2003, 83 (01) : 118A - 118A
  • [38] IS REFLEX MLH1 PROMOTER HYPERMETHYLATION TESTING FOLLOWING MLH1 LOSS BY IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL CARCINOMA BEST PRACTICE?
    Plotkin, Anna
    Olkhov-Mitsel, Ekaterina
    Nofech-Mozes, Sharon
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A26 - A27
  • [39] Haplotype analysis suggest that the MLH1 c.2059C > T mutation is a Swedish founder mutation
    Jenny von Salomé
    Tao Liu
    Markku Keihäs
    Moni Morak
    Elke Holinski-Feder
    Ian R. Berry
    Jukka S. Moilanen
    Stéphanie Baert-Desurmont
    Annika Lindblom
    Kristina Lagerstedt-Robinson
    [J]. Familial Cancer, 2018, 17 : 531 - 537
  • [40] Immunohistochemistry for MLH1, MSH2, MSH6, and PMS2 identifies most cases with germline HNPCC mutations and methylation of the MLH1 promoter
    Frankel, WL
    Hampel, H
    Nakagawa, H
    Morrison, C
    de la Chapelle, A
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 118A - 118A